Published in Clin Otolaryngol Allied Sci on February 01, 1994
Significance of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: initial results. Arch Otolaryngol Head Neck Surg (2010) 1.32
acp Best Practice No 169. Evidence based pathology: squamous carcinoma of the hypopharynx. J Clin Pathol (2003) 0.85
Current advances in diagnosis and surgical treatment of lymph node metastasis in head and neck cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg (2012) 0.83
Evaluation of the impact of addition of PET to CT and MR scanning in the staging of patients with head and neck carcinomas. Eur Arch Otorhinolaryngol (2006) 0.82
What the clinician wants to know: surgical perspective and ultrasound for lymph node imaging of the neck. Cancer Imaging (2005) 0.81
Genetic diagnosis of micrometastasis based on SCC antigen mRNA in cervical lymph nodes of head and neck cancer. Clin Exp Metastasis (1999) 0.81
Identification of circulating tumor cells: a prognostic marker in squamous cell carcinoma of the head and neck? Future Oncol (2011) 0.77
Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology. Head Neck (2016) 0.76
Nodal metastases from laryngeal carcinoma and their correlation with certain characteristics of the primary tumor. Indian J Otolaryngol Head Neck Surg (2002) 0.75
The prognostic value of location and size change of pathological lymph nodes evaluated on CT-scan following radiotherapy in head and neck cancer. Cancer Imaging (2017) 0.75
Tumour assessment and staging: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol (2016) 0.75
Morphological relationship between the superior cervical ganglion and cervical nerves in Japanese cadaver donors. Brain Behav (2016) 0.75
Concurrent chemoradiotherapy with S-1 in patients with stage III-IV oral squamous cell carcinoma: A retrospective analysis of nodal classification based on the neck node level. Mol Clin Oncol (2017) 0.75
The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer (2007) 3.15
Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer (1995) 2.47
Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer (2006) 1.84
Squamous carcinoma presenting as an enlarged cervical lymph node. Cancer (1993) 1.71
Morphological transformation of mouse embryo cells in vitro by murine sarcoma virus (Harvey). Nature (1967) 1.67
UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax (2011) 1.62
The health services utilisation of a general practice population. N Z Med J (1991) 1.52
Major conceptual change required to improve lung cancer: see a respiratory physician. Eur Respir J (2003) 1.40
K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification. Clin Chem (2000) 1.40
A randomised phase II trial of epirubicin and 5-fluorouracil versus cisplatinum in the palliation of advanced and recurrent malignant tumour of the salivary glands. Br J Cancer (1993) 1.39
Diaminobenzidine as a myelin stain in semithin plastic sections. Biotech Histochem (1999) 1.38
General practitioner consultations after a paediatric tonsillectomy. Int J Pediatr Otorhinolaryngol (1997) 1.38
Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol (2000) 1.30
Ultrastructure of a marine Synechococcus possessing spinae. Can J Microbiol (1981) 1.18
Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites. Br J Cancer (1998) 1.18
Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7. Cancer Res (1983) 1.15
Mucosal melanoma of the head and neck. Clin Otolaryngol Allied Sci (1998) 1.14
An electron microscopic study of macroglia and microglia in the lateral funiculus of the developing spinal cord in the fetal monkey. Z Zellforsch Mikrosk Anat (1973) 1.13
Cervical node metastases presenting with features of branchial cysts. J Laryngol Otol (1994) 1.11
Waiting times during the management of head and neck tumours. J Laryngol Otol (2002) 1.10
Synchronous oral carcinomas: independent or common clonal origin? Cancer Res (1998) 1.10
Do positive resection margins after ablative surgery for head and neck cancer adversely affect prognosis? A study of 352 patients with recurrent carcinoma following radiotherapy treated by salvage surgery. Br J Cancer (1996) 1.08
Implications of tumour in resection margins following surgical treatment of squamous cell carcinoma of the head and neck. Clin Otolaryngol Allied Sci (1993) 1.06
Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression. Am J Pathol (1998) 1.04
Occult node metastases in head and neck squamous carcinoma. Eur Arch Otorhinolaryngol (1993) 1.04
Day-case myringoplasty: five years' experience. J Laryngol Otol (2003) 1.04
Characteristics of mast cells in Chediak-Higashi mice: light and electron microscopic studies of connective tissue and mucosal mast cells. Exp Cell Biol (1983) 1.02
p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability. Cancer Res (1997) 1.01
Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives. Br J Cancer (2006) 1.01
Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol (2000) 1.01
Multiple transcriptional activation of cellular oncogenes in human head and neck solid tumours. Anticancer Res (1985) 1.00
hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas. Cancer Res (2000) 0.99
Does Candida have a role in oral epithelial neoplasia? J Med Vet Mycol (1989) 0.99
Sequencing of difficult templates containing poly(A/T) tracts: closure of sequence gaps. Biotechniques (2002) 0.99
LOH at the sites of the DCC, APC, and TP53 tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus. Hum Pathol (1999) 0.98
Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck. Int J Cancer (1996) 0.98
Tylosis associated with carcinoma of the oesophagus and oral leukoplakia in a large Liverpool family--a review of six generations. Eur J Cancer B Oral Oncol (1994) 0.98
How we do it: head and neck cancer waiting times. Clin Otolaryngol (2005) 0.98
Clinical relevance of oncogene expression in head and neck tumours. Anticancer Res (1986) 0.98
S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas. Br J Cancer (2004) 0.97
Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck. Br J Cancer (1995) 0.96
Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection. Clin Cancer Res (1999) 0.96
Long-term recurrence rates following excision and cartilage rim shave of chondrodermatitis nodularis chronica helicis and antihelicis. Clin Otolaryngol (2014) 0.96
METH-2 silencing and promoter hypermethylation in NSCLC. Br J Cancer (2004) 0.96
Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer. Br J Cancer (2009) 0.95
Overexpression of p53 gene in head-and-neck cancer, linked with heavy smoking and drinking. Lancet (1992) 0.95
Loss of heterozygosity studies on chromosome 17 in head and neck cancer using microsatellite markers. Oncogene (1994) 0.95
An investigation of the tylosis with oesophageal cancer (TOC) locus in Iranian patients with oesophageal squamous cell carcinoma. Int J Oncol (2004) 0.94
Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays. J Pathol (2003) 0.94
Comparison of discriminatory power and accuracy of three lung cancer risk models. Br J Cancer (2010) 0.94
Atypical lipoma of the tongue. J Laryngol Otol (2001) 0.93
Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer. Oncogene (1995) 0.92
Close mapping of the focal non-epidermolytic palmoplantar keratoderma (PPK) locus associated with oesophageal cancer (TOC). Hum Mol Genet (1996) 0.92
The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol (1994) 0.91
Expression of the cell-cell adhesion molecule E-cadherin in squamous cell carcinoma of the head and neck. Clin Otolaryngol Allied Sci (1993) 0.91
The clinical determinants of malignant transformation in oral epithelial dysplasia. Oral Oncol (2012) 0.91
Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma. Invest Ophthalmol Vis Sci (2001) 0.91
Cancer-specific genomic instability in bronchial lavage: a molecular tool for lung cancer detection. Cancer Res (2001) 0.90
Sensitivity and limitations of high throughput fluorescent microsatellite analysis for the detection of allelic imbalance: application in lung tumors. Int J Oncol (2000) 0.89
Smoking history and lung carcinoma: KRAS mutation is an early hit in lung adenocarcinoma development. Lung Cancer (2011) 0.89
Expression of oncogenes in human tumours with special reference to the head and neck region. J Oral Pathol (1987) 0.89
Sex differences in sexual needs and desires. Arch Sex Behav (1984) 0.89
Detection of the tumour suppressor gene p53 in nasopharyngeal carcinoma in Hong Kong Chinese. Anticancer Res (1994) 0.89
Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival. Br J Cancer (2002) 0.89
Absence of mutations in the VHL gene but frequent loss of heterozygosity at 3p25-26 in non-small cell lung carcinomas. Lung Cancer (2003) 0.89
Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic. Br J Oral Maxillofac Surg (2013) 0.88
Envoplakin, a possible candidate gene for focal NEPPK/esophageal cancer (TOC): the integration of genetic and physical maps of the TOC region on 17q25. Genomics (1999) 0.88
Malignant tumours of the cervical oesophagus. Clin Otolaryngol Allied Sci (1996) 0.88
Carcinosarcoma (malignant mixed tumor) of the submandibular gland: A case report and review of the literature. J Oral Maxillofac Surg (2002) 0.88
Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs). J Pathol (2001) 0.87
The effect of employment status and household composition on health care utilisation in a general practice. N Z Med J (1992) 0.87
Loss of heterozygosity in sporadic oesophageal tumors in the tylosis oesophageal cancer (TOC) gene region of chromosome 17q. Oncogene (1998) 0.86
Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease. Lung Cancer (2000) 0.86
A microcomputer program for analysis of nucleic acid hybridization data. Nucleic Acids Res (1982) 0.86
TP53 mutations in malignant and premalignant Barrett's esophagus. Dis Esophagus (2003) 0.86
Expression of ras Rb1 and p53 proteins in human breast cancer. Anticancer Res (1992) 0.85
Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics. Cancer Res (2001) 0.84
Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung. Anticancer Res (1990) 0.84
Recurrent pleomorphic adenoma. J Laryngol Otol (1993) 0.84
Expression of p16(INK4A) and alterations of the 9p21-23 chromosome region in non-small-cell lung carcinomas: relationship with tumor growth parameters and ploidy status. Int J Cancer (2000) 0.84
Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck. Oral Oncol (2003) 0.84
The inflammation produced by corticosteroid inhalers in the pharynx in asthmatics. Clin Otolaryngol (2008) 0.83
Von Hippel-Lindau tumour suppressor gene is not involved in sporadic human breast cancer. Tumour Biol (2001) 0.83
p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck. Int J Cancer (1997) 0.82
Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications. Oral Oncol (2000) 0.82
Tylosis oesophageal cancer mapped. Nat Genet (1994) 0.82
ras, c-myc and c-erbB-2 oncoproteins in human breast cancer. Anticancer Res (1990) 0.81
Microsatellite instability and p53 mutations in hepatocellular carcinoma. Mol Cell Biol Res Commun (2000) 0.81
c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types. Anticancer Res (1990) 0.81
A comparative guide to gene prediction tools for the bioinformatics amateur. Int J Oncol (2002) 0.81
The tylosis esophageal cancer (TOC) locus: more than just a familial cancer gene. Dis Esophagus (1999) 0.81
A systematic review of the characteristics associated with recall rates, detection rates and positive predictive values of computed tomography screening for lung cancer. Ann Oncol (2013) 0.81
A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neck. J Laryngol Otol (1994) 0.81
Oral tylosis: a re-appraisal. Oral Oncol (1997) 0.81
Primary amyloidosis of the external auditory canal: case report. J Laryngol Otol (1994) 0.81
Transoral laser resection versus lip-split mandibulotomy in the management of oropharyngeal squamous cell carcinoma (OPSCC): a case match study. Eur Arch Otorhinolaryngol (2013) 0.81